ABVC Biopharma Valuation
| ABVC Stock | USD 1.74 0.14 8.75% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. ABVC Biopharma shows a prevailing Real Value of $1.86 per share. The current price of the entity is $1.74. Our model approximates the value of ABVC Biopharma from reviewing the entity fundamentals such as Shares Owned By Insiders of 10.70 %, operating margin of (1.47) %, and Return On Asset of -0.17 as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that ABVC Biopharma's price fluctuation is dangerous at this time. Calculation of the real value of ABVC Biopharma is based on 3 months time horizon. Increasing ABVC Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ABVC Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABVC Stock. However, ABVC Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.74 | Real 1.86 | Hype 1.75 | Naive 1.73 |
The real value of ABVC Stock, also known as its intrinsic value, is the underlying worth of ABVC Biopharma Company, which is reflected in its stock price. It is based on ABVC Biopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ABVC Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ABVC Biopharma helps investors to forecast how ABVC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ABVC Biopharma more accurately as focusing exclusively on ABVC Biopharma's fundamentals will not take into account other important factors: About ABVC Biopharma Valuation
The stock valuation mechanism determines ABVC Biopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of ABVC Biopharma. We calculate exposure to ABVC Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ABVC Biopharma's related companies.ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |